Edition:
United States

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

9.64USD
21 Sep 2018
Change (% chg)

$0.21 (+2.23%)
Prev Close
$9.43
Open
$9.60
Day's High
$9.64
Day's Low
$9.25
Volume
49,088
Avg. Vol
98,161
52-wk High
$13.54
52-wk Low
$2.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.21 -0.407
Mar '18 0.00 -0.301
FY 2017 Dec '17 0.00 -0.254
Sep '17 0.00 -0.390
FY 2016 Dec '16 0.00 -0.187
Sep '16 0.00 -0.289
Jun '16 0.00 0.916
Mar '16 0.00 -0.807
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta -- 0.61 0.87
Price to Sales (TTM) -- 110.30 6.46
Price to Book (MRQ) -- 12.48 3.90
Price to Tangible Book (MRQ) -- 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago -- 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 2.11 5.49 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.24
Total Debt to Equity (MRQ) 0.12 18.62 14.06
Interest Coverage (TTM) -- -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -7,148.05 -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -7,148.05 -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -7,125.69 -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -7,125.69 -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,335,375 714,979,821
Net Income/Employee (TTM) -- -5,831,664 82,568,832
Receivable Turnover (TTM) -- 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) -- 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 0.80 9.75
Return on Assets - 5 Yr. Avg. -- 2.53 10.91
Return on Investment (TTM) -- 1.50 12.72
Return on Investment - 5 Yr. Avg. -- 2.04 14.03
Return on Equity (TTM) -- 0.19 14.85
Return on Equity - 5 Yr. Avg. -- -2.23 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for TapImmune Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.